DK1554305T3 - Prionprotein-bindende peptidsekvenser - Google Patents
Prionprotein-bindende peptidsekvenserInfo
- Publication number
- DK1554305T3 DK1554305T3 DK02779505T DK02779505T DK1554305T3 DK 1554305 T3 DK1554305 T3 DK 1554305T3 DK 02779505 T DK02779505 T DK 02779505T DK 02779505 T DK02779505 T DK 02779505T DK 1554305 T3 DK1554305 T3 DK 1554305T3
- Authority
- DK
- Denmark
- Prior art keywords
- prion protein
- peptide sequences
- protein binding
- binding peptide
- prp
- Prior art date
Links
- 102000029797 Prion Human genes 0.000 title abstract 3
- 108091000054 Prion Proteins 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- 102000001708 Protein Isoforms Human genes 0.000 abstract 1
- 108010029485 Protein Isoforms Proteins 0.000 abstract 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2002/011868 WO2004037854A1 (en) | 2002-10-23 | 2002-10-23 | Prion protein-binding peptide sequences |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1554305T3 true DK1554305T3 (da) | 2007-04-23 |
Family
ID=32116206
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02779505T DK1554305T3 (da) | 2002-10-23 | 2002-10-23 | Prionprotein-bindende peptidsekvenser |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1554305B1 (da) |
AT (1) | ATE358136T1 (da) |
AU (1) | AU2002342850A1 (da) |
DE (1) | DE60219215T2 (da) |
DK (1) | DK1554305T3 (da) |
ES (1) | ES2283608T3 (da) |
PT (1) | PT1554305E (da) |
WO (1) | WO2004037854A1 (da) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7439041B2 (en) | 2003-08-13 | 2008-10-21 | Novartis Vaccines And Diagnostics, Inc. | Prion-specific peptide reagents |
WO2007030804A1 (en) | 2005-09-09 | 2007-03-15 | Novartis Ag | Prion-specific peptoid reagents |
EP2049664B1 (en) | 2006-08-11 | 2011-09-14 | Prosensa Technologies B.V. | Single stranded oligonucleotides complementary to repetitive elements for treating DNA repeat instability associated genetic disorders |
NZ582521A (en) | 2007-07-12 | 2011-09-30 | Prosensa Technologies Bv | A conjugate comprising the amino acid sequence LGAQSNF for targeting compounds to muscle tissue |
USRE48468E1 (en) | 2007-10-26 | 2021-03-16 | Biomarin Technologies B.V. | Means and methods for counteracting muscle disorders |
DK2203173T3 (da) | 2007-10-26 | 2016-02-29 | Academisch Ziekenhuis Leiden | Midler og fremgangsmåder til modvirkning af muskellidelser |
EP2119783A1 (en) | 2008-05-14 | 2009-11-18 | Prosensa Technologies B.V. | Method for efficient exon (44) skipping in Duchenne Muscular Dystrophy and associated means |
WO2010123369A1 (en) | 2009-04-24 | 2010-10-28 | Prosensa Technologies B.V. | Oligonucleotide comprising an inosine for treating dmd |
CN104203289B (zh) | 2012-01-27 | 2020-11-03 | 比奥马林技术公司 | 用于治疗杜兴型肌营养不良症和贝克型肌营养不良症的具有改善特性的rna调节性寡核苷酸 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002514224A (ja) * | 1997-06-02 | 2002-05-14 | ザ レジェンツ オブ ザ ユニバーシティー オブ カリフォルニア | プリオン蛋白質調節因子(ppmf)およびプリオン抵抗性動物 |
GB9823835D0 (en) * | 1998-10-30 | 1998-12-23 | Univ London | Component for vaccine |
US6399575B1 (en) * | 1998-11-10 | 2002-06-04 | Auburn University | Methods and compositions for targeting compounds to the central nervous system |
MXPA01001885A (es) * | 1999-06-21 | 2002-04-24 | Inkine Pharmaceutical Company | Angiocidina: un receptor de adhesion a celula tumoral especifico de cys-ser-val-thr-cys-gly. |
AU2002236499A1 (en) * | 2000-11-30 | 2002-06-11 | Uab Research Foundation | Receptor-mediated uptake of peptides that bind the human transferrin receptor |
CA2436789A1 (en) * | 2000-12-19 | 2002-08-22 | Palatin Technologies, Inc. | Identification of target-specific folding sites in peptides and proteins |
-
2002
- 2002-10-23 WO PCT/EP2002/011868 patent/WO2004037854A1/en active IP Right Grant
- 2002-10-23 AT AT02779505T patent/ATE358136T1/de not_active IP Right Cessation
- 2002-10-23 AU AU2002342850A patent/AU2002342850A1/en not_active Abandoned
- 2002-10-23 EP EP02779505A patent/EP1554305B1/en not_active Expired - Lifetime
- 2002-10-23 DK DK02779505T patent/DK1554305T3/da active
- 2002-10-23 PT PT02779505T patent/PT1554305E/pt unknown
- 2002-10-23 ES ES02779505T patent/ES2283608T3/es not_active Expired - Lifetime
- 2002-10-23 DE DE60219215T patent/DE60219215T2/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1554305B1 (en) | 2007-03-28 |
DE60219215D1 (de) | 2007-05-10 |
ATE358136T1 (de) | 2007-04-15 |
WO2004037854A1 (en) | 2004-05-06 |
ES2283608T3 (es) | 2007-11-01 |
AU2002342850A1 (en) | 2004-05-13 |
DE60219215T2 (de) | 2008-01-03 |
PT1554305E (pt) | 2007-05-31 |
EP1554305A1 (en) | 2005-07-20 |
AU2002342850A8 (en) | 2004-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1124802T1 (el) | Δεσμευτικοι παραγοντες σκληροστινης | |
GB2433936A (en) | Therapeutic peptides comprising sequences derived from CDR2 or CDR3 of trem-1 and uses thereof to inhibit sepsis | |
DE602004006433D1 (de) | Pyrrol-substituierte indole als inhibitoren von pai-1 | |
CY1111225T1 (el) | Νεα πεπτιδια ως αναστολεις πρωτεασης νs3-σερινης ιου ηπατiτιδας c | |
MA32982B1 (fr) | Proteines de liaison au recepteur cgrp humain | |
IL232501A (en) | Peptide or polypeptide-resistant protein analogs and their uses | |
BRPI0517973A (pt) | método para purificar o fsh | |
WO2006023844A3 (en) | Compositions and methods comprising proteinase activated receptor antagonists | |
WO2007076055A3 (en) | Compositions and methods comprising proteinase activated receptor antagonists | |
NO20063064L (no) | Ny anvendelse av peptidforbindelser for behandling av sentralneurotisk smerte | |
ATE267830T1 (de) | Als cox-hemmer verwendbare sulfonylphenylpyrazol- verbindungen | |
NO20090624L (no) | Forbindelser som modulerer CB2 receptoren | |
GEP20115324B (en) | Tweak binding antibodies | |
WO2003100033A3 (en) | ANTI-αvβ6 ANTIBODIES | |
EA200801180A1 (ru) | Селективные пептидные агонисты рецептора vpac2 | |
CY1112673T1 (el) | Φαινοξυ αιθερες αμινοξεων | |
MX2008000230A (es) | Proteinas de enlace il-6. | |
NO20083050L (no) | Forbindelser og fremgangsmater for hemming av interaksjon av Bcl-proteiner med bindingspartnere | |
WO2004002418A3 (en) | Compositions and methods comprising protein activated receptor antagonists | |
DK1554305T3 (da) | Prionprotein-bindende peptidsekvenser | |
DE50013435D1 (de) | Peptide gegen dcm hervorrufende autoantikörper | |
DE60207043D1 (de) | Histidine-rich glycoprotein (hrgp) zur hemmung der angiogenese | |
ATE247130T1 (de) | Inhibitoren für den urokinaserezeptor | |
UA87117C2 (ru) | Применение пептидных соединений для лечения центральной невропатической боли | |
CY1109904T1 (el) | Προαγωγεας της il-18bp, η παρασκευη και χρηση του |